Benzenesulfonates
Research News and Information

Sunday, March 21, 2010

Alveolar rhabdomyosarcoma of the extremity and nodal metastasis: Is the in-transit lymphatic system at risk?

13 Dec 2009 Alveolar rhabdomyosarcoma (RMS) of the extremity is not infrequently associated with regional node metastasis. Knowledge of lymphatic drainage of extremity RMSs is important to determine radiotherapy fields. In this report we describe two patients ... Read more...

Sorafenib reveals efficacy in sequential treatment of metastatic renal cell cancer.

29 Sep 2009 Metastatic renal cell carcinoma (mRCC) is a highly vascularized tumor with a generally poor prognosis. It is largely resistant to conventional cancer treatment, including most schemes of hormonal and cytokine therapy as well as to modern ... Read more...

Promoting neurite outgrowth from spiral ganglion neuron explants using polypyrrole/BDNF-coated electrodes.

29 Sep 2009 Release of neurotrophin-3 (NT3) and brain-derived neurotrophic factor (BDNF) from hair cells in the cochlea is essential for the survival of spiral ganglion neurons (SGNs). Loss of hair cells associated with a sensorineural hearing loss therefore ... Read more...

Latest indexed articles for 'Benzenesulfonates'

These are the very latest articles for this heading:

• Alveolar rhabdomyosarcoma of the extremity and nodal metastasis: Is the in-transit lymphatic system at risk? 13 Dec 2009
• Sorafenib reveals efficacy in sequential treatment of metastatic renal cell cancer. 29 Sep 2009
• Promoting neurite outgrowth from spiral ganglion neuron explants using polypyrrole/BDNF-coated electrodes. 29 Sep 2009
• Diffusion-weighted MRI of advanced hepatocellular carcinoma during sorafenib treatment: initial results. 29 Sep 2009
• Down-regulation of HLA Class I and NKG2D ligands through a concerted action of MAPK and DNA methyltransferases in colorectal cancer cells. 29 Sep 2009
• Proton transfer versus nontransfer in compounds of the diazo-dye precursor 4-(phenyldiazenyl)aniline (aniline yellow) with strong organic acids: the 5-sulfosalicylate and the dichroic benzenesulfonate salts, and the 1:2 adduct with 3,5-dinitrobenzoic acid. 28 Sep 2009
• Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials. 16 Sep 2009
• Phase 2 trial of sorafenib in patients with advanced urothelial cancer: a trial of the Eastern Cooperative Oncology Group. 13 Sep 2009
• Aurora kinase inhibitor PHA-739358 suppresses growth of hepatocellular carcinoma in vitro and in a xenograft mouse model. 30 Aug 2009
• Targeted therapies: Role of sorafenib in HCC patients with compromised liver function. 30 Aug 2009
• Targeted therapies in the treatment of advanced/metastatic NSCLC. 30 Aug 2009
• Brain magnetic resonance imaging changes after sorafenib and sunitinib chemotherapy in patients with advanced renal cell and breast carcinoma. 30 Aug 2009
• The histologic spectrum of epithelial neoplasms induced by sorafenib. 30 Aug 2009
• Predicting the response to sorafenib in hepatocellular carcinoma: where is the evidence for phosphorylated extracellular signaling-regulated kinase (pERK)? 22 Aug 2009
• Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitro study. 22 Aug 2009
• UGT1A1 polymorphism and hyperbilirubinemia in a patient who received sorafenib. 10 Aug 2009
• [Molecular targeted drugs in the developmental stage: 2) Various molecular targets and therapeutic agents under investigation] 8 Aug 2009
• Long-term response in primary renal cancer to sequential antiangiogenic therapy. 8 Aug 2009
• Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma. Aug 2009
• Phase II study of sorafenib in patients with sunitinib-refractory metastatic renal cell cancer. Aug 2009

See a longer list of these articles.

Technical information about 'Benzenesulfonates'

Definition: Organic salts and esters of benzenesulfonic acid.

Registry Number: 0

Descriptor UI: D001557

Alternative terms: Benzenesulfonates;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D02.455.426.559.389.097; D02.886.645.600.080.050.100;

History Note: 74